Pharmaceutical companies attempt to maximize their Medicaid sales by luring doctors with consulting fees and dinners, and by paying speakers to testify positively about their drugs, according to an investigation from The Center for Public Integrity and NPR.

Go deeper: Read the story, which outlines how one doctor in Arizona who promoted schizophrenia drugs received $700,000 from the industry.